All the news Showing 10 of 448 articles from: TherapiesGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Treatment Action Group publishes Guide to Clinical Trials for People With Hepatitis C Treatment Action Group / 17 August 2011 UK-Victrelis-Boceprevir HCV Drug Launched Hepatitis C New Drugs blog / 10 August 2011 Interim Data from Phase 2 Study of Combination Regimen Including VX-222 and INCIVEK™ Suggest Potential to Treat Genotype 1 Hepatitis C in as few as 12 Weeks and No More Than 24 Weeks Vertex (press release) / 27 July 2011 New Vertex hepatitis C ads focus on disease, not treatment Boston Globe / 30 June 2011 Vertex Tops Merck in Early Hep C Drug Launch The Street / 28 June 2011 Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment The Body / 03 June 2011 High Demand for New HCV Drugs Could Cause Ethical Problems Medscape / 31 May 2011 NICE to appraise hep C drugs Victrelis and telaprevir InPharm / 26 May 2011 Achillion Announces Initiation of Phase 1 Trial of ACH-2684 for the Treatment of Hepatitis C Achillion / 26 May 2011 European approval for new hepatitis C drug boceprevir (Victrelis) European Medicines Agency / 20 May 2011 ← Prev1...4041424344...45Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive